208 related articles for article (PubMed ID: 4027484)
1. Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.
Berrie CP; Birdsall NJ; Hulme EC; Keen M; Stockton JM
Br J Pharmacol; 1985 Jul; 85(3):697-703. PubMed ID: 4027484
[TBL] [Abstract][Full Text] [Related]
2. The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.
Birdsall NJ; Hulme EC; Keen M
Br J Pharmacol; 1986 Feb; 87(2):307-16. PubMed ID: 3754173
[TBL] [Abstract][Full Text] [Related]
3. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
4. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
el-Fakahany EE; Ramkumar V; Lai WS
J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
7. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxy-1-propanesulfonate.
Poyner DR; Birdsall NJ; Curtis C; Eveleigh P; Hulme EC; Pedder EK; Wheatley M
Mol Pharmacol; 1989 Sep; 36(3):420-9. PubMed ID: 2506431
[TBL] [Abstract][Full Text] [Related]
8. The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives.
Trybulski EJ; Zhang J; Kramss RH; Mangano RM
J Med Chem; 1993 Nov; 36(23):3533-41. PubMed ID: 8246221
[TBL] [Abstract][Full Text] [Related]
9. Evidence of paired M2 muscarinic receptors.
Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
[TBL] [Abstract][Full Text] [Related]
10. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
12. Solubilization with digitonin alters the kinetics of pirenzepine binding to muscarinic receptors from rat forebrain and heart.
Wang JX; Mei L; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1987 Sep; 242(3):981-90. PubMed ID: 3116203
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors.
Wreggett KA; Wells JW
J Biol Chem; 1995 Sep; 270(38):22488-99. PubMed ID: 7673239
[TBL] [Abstract][Full Text] [Related]
14. Solubilization and characterization of atrial muscarinic acetylcholine receptors in sucrose monolaurate.
Rinken A; Haga T
Arch Biochem Biophys; 1993 Feb; 301(1):158-64. PubMed ID: 8442658
[TBL] [Abstract][Full Text] [Related]
15. Temperature effect on subclasses of muscarinic receptors in rat colon, heart and cerebral cortex.
Muzio F; Malandrino S; Ferrari M; Tonon G
Life Sci; 1986 Jul; 39(4):365-71. PubMed ID: 3755491
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of solubilized muscarinic cholinergic receptors: binding and hydrodynamic properties.
Baron B; Gavish M; Sokolovsky M
Arch Biochem Biophys; 1985 Jul; 240(1):281-96. PubMed ID: 4015105
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
18. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
Adem A; Sabbagh M; Nordberg A
J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
[TBL] [Abstract][Full Text] [Related]
19. Regional heterogeneity of muscarinic acetylcholine receptors from rat brain is retained after detergent solubilization.
Wenger DA; Parthasarthy N; Aronstam RS
Neurosci Lett; 1985 Feb; 54(1):65-70. PubMed ID: 3974946
[TBL] [Abstract][Full Text] [Related]
20. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
